Korro Bio
Valuation
$99.3M
Funding
$0
Founded
2014
Korro Bio revenue, CEO Kieron Burrows, team size, customer count, churn, and more in 2026.
Korro Bio is a biopharmaceutical company with a mission to discover, develop and commercialize a new class of genetic medicines based on editing RNA, enabling treatment of both rare and highly prevalent diseases.
Last updated
Korro Bio Revenue
We do not have information about Korro Bio's revenue yet.
Korro Bio Valuation, Funding Rounds
Korro Bio's most recent disclosed valuation is $99.3M.
Korro Bio is a bootstrapped SaaS company, self-funded since its founding in 2014, with no outside investment to date.
| Year | Round | Amount | Valuation | % Sold |
|---|
Korro Bio Employees & Team Size
We do not have information about Korro Bio's team yet.
Founder / CEO
Kieron Burrows
Kieron Burrows is listed as Founder / CEO at Korro Bio.
Q&A
| Question | Answer |
|---|---|
| What's your age? | - |
| Favorite online tool? | - |
| Favorite book? | - |
| Favorite CEO? | - |
| Advice for 20 year old self | - |
Customers
We do not have customer count information for Korro Bio yet.
Frequently Asked Questions about Korro Bio
What is Korro Bio's revenue?
GetLatka has not confirmed a public revenue figure for Korro Bio.
Who is the CEO of Korro Bio?
The CEO of Korro Bio is Kieron Burrows.
How much funding does Korro Bio have?
Korro Bio raised $0.
How many employees does Korro Bio have?
Korro Bio has 0 employees.
Where is Korro Bio headquarters?
Korro Bio is headquartered in Cambridge, Massachusetts, United States.
Source Attribution
Source: all data was collected from GetLatka company research and founder interviews. Revenue, funding, team, and customer figures are presented as company-reported or GetLatka-estimated metrics where the profile data identifies them that way.
Company data last updated .